Related Experiment Video
Updated: Oct 13, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotics for the prevention of pediatric upper respiratory tract infections: a systematic review
Metehan Ozen1, Gonca Kocabas Sandal, Ener Cagri Dinleyici
1Department of Pediatrics, Acibadem University Faculty of Medicine , Istanbul , Turkey.
Insights
Prophylactic probiotic use in children modestly reduces the incidence and severity of acute upper respiratory tract infections (URTIs). Long-term administration of probiotics is safe for children, showing no serious adverse events.
Area of Science:
- Pediatric Infectious Diseases
- Microbiome Research
- Public Health
Background:
- Acute upper respiratory tract infections (URTIs) are a major cause of illness in children globally.
- Preventing URTIs in childhood is a significant public health concern.
- Previous reviews suggest probiotics may be beneficial for URTIs, but evidence is limited.
Purpose of the Study:
- To evaluate the efficacy of prophylactic probiotic use in preventing URTIs in children.
- To focus specifically on the pediatric population for probiotic intervention in URTIs.
Main Methods:
- Systematic review of 14 high-quality randomized controlled trials (RCTs) from two databases (inception to June 2014).
- Focused on Lactobacillus and Bifidobacterium strains for their effects on URTI incidence and symptom scores in healthy children.
- Data extraction and quality assessment performed by two independent reviewers.
Main Results:
- Probiotics demonstrate a modest effect in reducing both the incidence and symptom severity of URTIs in immunocompetent children.
- The review provides the first comprehensive evaluation of specific probiotic strains for URTI prevention in pediatric populations.
Conclusions:
- Prophylactic probiotic administration showed at least one beneficial effect in most RCTs.
- Even a small reduction in URTI incidence (5-10%) has significant clinical and economic implications.
- Long-term probiotic use in childhood is safe, with no reported serious adverse events.
Background:
Acute upper respiratory tract infections (URTIs) contribute substantially to pediatric morbidity and mortality worldwide. Prevention of these infections in childhood is a very important public health challenge. Previous systematic reviews, including both adult and childhood populations, have reported that probiotics seem promising, but with modest evidence. This study aimed to focus on prophylactic probiotic use in the prevention of URTIs in childhood.
Methods:
Relevant trials on two databases were identified in a systematic review, from inception to June 2014. Study selection, data extraction and quality assessment were carried out by two reviewers. In this review, the effects of probiotics, particularly the Lactobacillus and Bifidobacterium strains, on the incidence and symptom scores of URTI in otherwise healthy children were evaluated for the first time. This review comprises 14 randomized controlled trials (RCTs) applied to a pediatric population with high-quality methodology.
Results:
This systematic review suggests that probiotics in immunocompetent children have a modest effect both in diminishing the incidence of URTIs and the severity of the infection symptoms.
Conclusions:
At least one beneficial effect of prophylactic probiotic was observed in the majority of RCTs. Even a minimal reduction of 5 - 10% in the incidence of URTIs would have an important clinical and economic mpact on societies. Furthermore, the long-term administration of probiotics appeared to have a good safety profile in childhood and none of the studies reported any serious adverse events related to the probiotic strain.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Probiotics
Microbiota of the Respiratory Tract
Microbiota Modulation by Antibiotics
Respiratory Syncytial Virus Disease

